The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
Description
Approximately 3% of US adults are immunocompromised and less capable of fighting infections such as SARS-CoV-2 (the causative agent of COVID-19). Individuals may be immunocompromised for reasons related to an underlying medical condition or to
